within Pharmacolibrary.Drugs.P_AntiparasiticProductsInsecticidesAndRepellents.P01A_AgentsAgainstAmoebiasisAndOtherProtozoalDiseases.P01AB07_Secnidazole;

model Secnidazole
  extends Pharmacolibrary.Drugs.ATC.P.P01AB07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>P01AB07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Secnidazole is a nitroimidazole antimicrobial agent primarily used for the treatment of protozoal infections including amoebiasis, giardiasis, and trichomoniasis. It is similar to metronidazole but has a longer half-life, enabling single-dose oral therapies. Secnidazole is approved for use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects (both sexes, mean age ~27 years) after administration of a single oral dose.</p><h4>References</h4><ol><li><p>Mergenhagen, KA, et al., &amp; Russo, TA (2020). Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=\"https://doi.org/10.1128/AAC.02167-19\">10.1128/AAC.02167-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31871085/\">https://pubmed.ncbi.nlm.nih.gov/31871085</a></p></li><li><p>Lamp, KC, et al., &amp; Lacy, MK (1999). Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. <i>Clinical pharmacokinetics</i> 36(5) 353–373. DOI:<a href=\"https://doi.org/10.2165/00003088-199936050-00004\">10.2165/00003088-199936050-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10384859/\">https://pubmed.ncbi.nlm.nih.gov/10384859</a></p></li><li><p>Zhu, DQ, et al., &amp; Chen, J (2007). Evaluation of the bioequivalence and pharmacokinetics of two formulations of secnidazole after single oral administration in healthy volunteers. <i>Arzneimittel-Forschung</i> 57(11) 723–726. DOI:<a href=\"https://doi.org/10.1055/s-0031-1296674\">10.1055/s-0031-1296674</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18193695/\">https://pubmed.ncbi.nlm.nih.gov/18193695</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Secnidazole;
